Cargando…
Target users’ acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)
BACKGROUND: Pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) is a highly effective way to reduce virus transmission. There have been increasing calls to improve access to PrEP in Canada. One way to improve access is by having more prescribers available. The objective of this st...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331363/ https://www.ncbi.nlm.nih.gov/pubmed/37435507 http://dx.doi.org/10.1177/17151635231177027 |
_version_ | 1785070241442693120 |
---|---|
author | MacDonald, Calum B. Murphy, Andrea L. Isenor, Jennifer E. Ramsey, Tasha D. Furlotte, Kirk Smith, Alesha J. Bishop, Andrea Kelly, Deborah V. Woodill, Lisa Booker, Connor Wilby, Kyle John |
author_facet | MacDonald, Calum B. Murphy, Andrea L. Isenor, Jennifer E. Ramsey, Tasha D. Furlotte, Kirk Smith, Alesha J. Bishop, Andrea Kelly, Deborah V. Woodill, Lisa Booker, Connor Wilby, Kyle John |
author_sort | MacDonald, Calum B. |
collection | PubMed |
description | BACKGROUND: Pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) is a highly effective way to reduce virus transmission. There have been increasing calls to improve access to PrEP in Canada. One way to improve access is by having more prescribers available. The objective of this study was to determine target users’ acceptance of a PrEP-prescribing service by pharmacists in Nova Scotia. METHODS: A triangulation, mixed-methods study was conducted consisting of an online survey and qualitative interviews underpinned by the Theoretical Framework of Acceptability (TFA) constructs (affective attitude, burden, ethicality, intervention coherence, opportunity cost, perceived effectiveness and self-efficacy). Participants were those eligible for PrEP in Nova Scotia (men who have sex with men or transgender women, persons who inject drugs and HIV-negative individuals in serodiscordant relationships). Descriptive statistics and ordinal logistic regression were used to analyze survey data. Interview data were deductively coded according to each TFA construct and then inductively coded to determine themes within each construct. RESULTS: A total of 148 responses were captured by the survey, and 15 participants were interviewed. Participants supported pharmacists’ prescribing PrEP across all TFA constructs from both survey and interview data. Identified concerns related to pharmacists’ abilities to order and view lab results, pharmacists’ knowledge and skills for sexual health and the potential for experiencing stigma within pharmacy settings. CONCLUSION: A pharmacist-led PrEP-prescribing service is acceptable to eligible populations in Nova Scotia. The feasibility of PrEP prescribing by pharmacists should be pursued as an intervention to increase access to PrEP. |
format | Online Article Text |
id | pubmed-10331363 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-103313632023-07-11 Target users’ acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) MacDonald, Calum B. Murphy, Andrea L. Isenor, Jennifer E. Ramsey, Tasha D. Furlotte, Kirk Smith, Alesha J. Bishop, Andrea Kelly, Deborah V. Woodill, Lisa Booker, Connor Wilby, Kyle John Can Pharm J (Ott) Research and Clinical BACKGROUND: Pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) is a highly effective way to reduce virus transmission. There have been increasing calls to improve access to PrEP in Canada. One way to improve access is by having more prescribers available. The objective of this study was to determine target users’ acceptance of a PrEP-prescribing service by pharmacists in Nova Scotia. METHODS: A triangulation, mixed-methods study was conducted consisting of an online survey and qualitative interviews underpinned by the Theoretical Framework of Acceptability (TFA) constructs (affective attitude, burden, ethicality, intervention coherence, opportunity cost, perceived effectiveness and self-efficacy). Participants were those eligible for PrEP in Nova Scotia (men who have sex with men or transgender women, persons who inject drugs and HIV-negative individuals in serodiscordant relationships). Descriptive statistics and ordinal logistic regression were used to analyze survey data. Interview data were deductively coded according to each TFA construct and then inductively coded to determine themes within each construct. RESULTS: A total of 148 responses were captured by the survey, and 15 participants were interviewed. Participants supported pharmacists’ prescribing PrEP across all TFA constructs from both survey and interview data. Identified concerns related to pharmacists’ abilities to order and view lab results, pharmacists’ knowledge and skills for sexual health and the potential for experiencing stigma within pharmacy settings. CONCLUSION: A pharmacist-led PrEP-prescribing service is acceptable to eligible populations in Nova Scotia. The feasibility of PrEP prescribing by pharmacists should be pursued as an intervention to increase access to PrEP. SAGE Publications 2023-06-12 /pmc/articles/PMC10331363/ /pubmed/37435507 http://dx.doi.org/10.1177/17151635231177027 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Research and Clinical MacDonald, Calum B. Murphy, Andrea L. Isenor, Jennifer E. Ramsey, Tasha D. Furlotte, Kirk Smith, Alesha J. Bishop, Andrea Kelly, Deborah V. Woodill, Lisa Booker, Connor Wilby, Kyle John Target users’ acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) |
title | Target users’ acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) |
title_full | Target users’ acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) |
title_fullStr | Target users’ acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) |
title_full_unstemmed | Target users’ acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) |
title_short | Target users’ acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) |
title_sort | target users’ acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (prep) for human immunodeficiency virus (hiv) |
topic | Research and Clinical |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331363/ https://www.ncbi.nlm.nih.gov/pubmed/37435507 http://dx.doi.org/10.1177/17151635231177027 |
work_keys_str_mv | AT macdonaldcalumb targetusersacceptanceofapharmacistledprescribingserviceforpreexposureprophylaxisprepforhumanimmunodeficiencyvirushiv AT murphyandreal targetusersacceptanceofapharmacistledprescribingserviceforpreexposureprophylaxisprepforhumanimmunodeficiencyvirushiv AT isenorjennifere targetusersacceptanceofapharmacistledprescribingserviceforpreexposureprophylaxisprepforhumanimmunodeficiencyvirushiv AT ramseytashad targetusersacceptanceofapharmacistledprescribingserviceforpreexposureprophylaxisprepforhumanimmunodeficiencyvirushiv AT furlottekirk targetusersacceptanceofapharmacistledprescribingserviceforpreexposureprophylaxisprepforhumanimmunodeficiencyvirushiv AT smithaleshaj targetusersacceptanceofapharmacistledprescribingserviceforpreexposureprophylaxisprepforhumanimmunodeficiencyvirushiv AT bishopandrea targetusersacceptanceofapharmacistledprescribingserviceforpreexposureprophylaxisprepforhumanimmunodeficiencyvirushiv AT kellydeborahv targetusersacceptanceofapharmacistledprescribingserviceforpreexposureprophylaxisprepforhumanimmunodeficiencyvirushiv AT woodilllisa targetusersacceptanceofapharmacistledprescribingserviceforpreexposureprophylaxisprepforhumanimmunodeficiencyvirushiv AT bookerconnor targetusersacceptanceofapharmacistledprescribingserviceforpreexposureprophylaxisprepforhumanimmunodeficiencyvirushiv AT wilbykylejohn targetusersacceptanceofapharmacistledprescribingserviceforpreexposureprophylaxisprepforhumanimmunodeficiencyvirushiv |